Poor
Mostly Aligned
Patient Risk:
Low
Summary
Overall alignment is poor. The extracted claims largely do not map to the provided prescribing information for Hydrocortisone Rectal Suspension, USP. Only a subset of statements about corticosteroid effects on infection risk and systemic absorption have partial support; the majority of wound-care and topical-wound claims are not addressed by the label.
Category Scores
Accurate Statements
Topical corticosteroids like hydrocortisone suppress inflammation and immune responses.
Partially supported
Hydrocortisone may cause systemic absorption leading to adrenal suppression with overuse.
Partially supported
Suppression can increase infection risk.
Supported
Unsupported Statements
Hydrocortisone cream should not be applied to open wounds.
Not supported by the provided label sections.
Suppression can delay healing.
Not supported by the provided label sections.
Suppression can impair skin barrier repair in broken skin.
Not supported by the provided label sections.
Hydrocortisone reduces collagen production.
Not supported by the provided label sections.
Hydrocortisone reduces fibroblast activity needed for wound closure.
Not supported by the provided label sections.
Hydrocortisone thins the epidermis on open wounds.
Not supported by the provided label sections.
Hydrocortisone promotes bacterial growth (e.g., Staphylococcus) on open wounds.
Not supported by the provided label sections.
Corticosteroids prolong healing time by 20-30% in acute wounds.
Not supported by the provided label sections.
Bacitracin can be used for minor wounds.
Not supported by the provided label sections.
Neomycin can be used for minor wounds.
Not supported by the provided label sections.
Silver sulfadiazine can be used for infected or larger wounds.
Not supported by the provided label sections.
Honey-based dressings can be used for infected or larger wounds.
Not supported by the provided label sections.
Hydrocortisone can be used on intact skin for itch or rash near a wound.
Not supported by the provided label sections.
Hydrocortisone should be applied with a 1-2 cm buffer from the edge of the wound.
Not supported by the provided label sections.
After the wound scabs and closes (typically 7-14 days), hydrocortisone near the wound may be safe if inflammation persists.
Not supported by the provided label sections.
Redness spreading, pus, fever, or no improvement in 48 hours signal infection worsened by steroids.
Not supported by the provided label sections.
Diabetics face higher risks with hydrocortisone use around wounds.
Not supported by the provided label sections.
Immunocompromised patients face higher risks with hydrocortisone use around wounds.
Not supported by the provided label sections.
Consult a doctor or pharmacist before use.
Not supported by the provided label sections.
Contradictions
Important Omissions
No wound-specific guidance (e.g., use around wounds, edge effects, buffering, timing, and monitoring for infection) is provided in the label. No guidance on topical hydrocortisone use for intact skin near wounds, wound healing timelines, or wound dressing interactions is present.
Importance:
Moderate
Safety Assessment
Potential Patient Risk:
Low
Label notes systemic absorption potential and infection-masking risk with corticosteroids; however, many external wound-care claims are not supported by the label, keeping overall risk assessment low if used per label.
Regulatory Assessment
| On Label |
Yes |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
Low |
Recommendation
Mostly Aligned
Primary Issue
Widespread extrapolation of wound-care and topical-wound claims not supported by the label.
Suggested Improvement
Limit claims to the label's Indication/Usage (ulcerative colitis) and known pharmacology (absorption, systemic effects, infection masking). Avoid asserting wound-management or non-label uses without explicit label support.